Merrimack Pharmaceuticals Inc. Reports Fourth Quarter and Full Year 2012 Financial Results

Published: Mar 14, 2013

CAMBRIDGE, Mass., March 14, 2013 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK), a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer, today announced its fourth quarter and full year 2012 financial results.

Back to news